Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

50.05 -3.56 (-6.64%)
Streaming Delayed Price Updated: 11:28 AM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns ↗
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Nancy Pelosi, Cathie Wood Align On These 4 Stocks – Do You Own Any? ↗
Shared stocks between Nancy Pelosi and Cathie Wood include Alphabet, Amazon, NVIDIA, and Tempus AI. They also both own stakes in private company Databricks. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus AI Up Nearly 185% Since Nancy Pelosi's Reported Purchase In January 2025 ↗
Track Nancy Pelosi's 2025 stock trades. Disclosures reveal a Tempus AI (TEM) options buy nets huge gains along with a Broadcom move. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI's $100 Breakout — Billionaire Cliff Asness Reaps 60% Windfall ↗
Tempus AI (TEM) stock has soared past $100, giving a 60% boost to billionaire Cliff Asness' TEM position in the AI-diagnostic stock. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus AI Executive Ryan Fukushima Sells $460,000 Worth Of Stock ↗
Tempus AI stock nudged higher after hours following insider sales by COO Ryan Fukushima's spouse under a pre-arranged trading plan. 
Via Benzinga
Topics Artificial Intelligence
News headline image
These 5 Beaten-Down Tech Stocks Could Catch Fire Next ↗
Highly shorted stocks with positive growth outlooks and improving market support are set up for short squeezes: this is a look at five. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Nancy Pelosi's Tempus Play Might Be Smartest Trade In Washington — Stock Surges 200% ↗
An AI stock disclosed as a new 2025 purchase by Nancy Pelosi is up over 200% since she took the position in January. 
Via Benzinga
Topics Artificial Intelligence
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Why Tempus AI Stock Was Motoring Higher This Week ↗
A recent acquisition seems to be paying off already for the tech-forward healthcare data specialist. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants
As of October 1, 2025, Artificial Intelligence (AI) has transcended its nascent stages, becoming an indispensable force in high-value professional tasks across medicine, law, and consulting. This... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
Tempus AI (TEM) Stock Is Rising Wednesday: What's Going On? ↗
Shares of Tempus AI Inc (NASDAQ: TEM) are trading higher Wednesday, potentially building on momentum from last week given the lack of company-specific news. Here's what investors need to know. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density
From Ambry Genetics
Via Business Wire
News headline image
Affirm Holdings, Oklo, Tempus AI Are Among Top 10 Large Cap Losers Last Week (Sep. 22- Sep. 26): Are The Others In Your Portfolio? ↗
These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio? 
Via Benzinga
Topics Artificial Intelligence
News headline image
3 Healthcare Stocks Using AI to Drive Growth ↗
AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation 
Via MarketBeat
Topics Artificial Intelligence
News headline image
What Are 2 Great Tech Stocks to Buy Right Now? ↗
These two tech stocks could deliver big returns for investors willing to hold for the long term. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
7 Analysts Have This To Say About Tempus AI ↗
Tempus AI (NASDAQ: TEM) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings,... 
Via Benzinga
Topics Artificial Intelligence
News headline image
Why Tempus AI Stock Is Plunging This Week ↗
When a well-known growth investor decides to trim her position in a stock, investors sit up and take note. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Cathie Wood Makes Trading Blitz: Buys Alibaba Stock Woth $11 Million, Dumps AMD And This AI Stock ↗
On Wednesday Sept. 24, 2025, Cathie Wood-led Ark Invest purchased nearly $11 million worth of Alibaba stock while selling shares of AMD and Tempus AI. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead ↗
Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades. 
Via Benzinga
Topics Artificial Intelligence
News headline image
IBD 50's Tempus AI Hits Record High On Yet Another FDA Clearance ↗
The company is focusing on RNA sequencing as a means of assisting with drug development. 
Via Investor's Business Daily
Topics Artificial Intelligence Intellectual Property
News headline image
Tempus AI (TEM) Stock Is Rising Monday: What's Going On? ↗
Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD device. 
Via Benzinga
Topics Artificial Intelligence
News headline image
3 Big Short Interest Names with Bullish Setups ↗
HIMS, DLO, and TEM combine high short interest with bullish chart setups, creating strong breakout potential as market momentum stays hot. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device
From Tempus AI, Inc.
Via Business Wire
News headline image
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225% ↗
On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA), 
Via Benzinga
Topics Artificial Intelligence
News headline image
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NASDAQ:CRSP),(NASDAQ:BNTX),(NYSE:BMY) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI ↗
On Tuesday, Cathie Wood-led Ark Invest executed significant trades, including buying shares of Advanced Micro Devices Inc. (NASDAQ:AMD) and Bullish Inc. (NYSE:BLSH), while selling shares o 
Via Benzinga
News headline image
What's Going On With Tempus AI Stock Monday? ↗
Tempus AI stock is trading marginally lower on Monday. Recent bullish sentiment follows last Thursday's announcement that Tempus AI received 510(k) clearance from the FDA. 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.